{"id":"https://openalex.org/W2411366386","doi":"https://doi.org/10.5414/cpp46389","title":"The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II","display_name":"The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II","publication_year":2008,"publication_date":"2008-08-01","ids":{"openalex":"https://openalex.org/W2411366386","doi":"https://doi.org/10.5414/cpp46389","mag":"2411366386","pmid":"https://pubmed.ncbi.nlm.nih.gov/18793580"},"language":"en","primary_location":{"id":"doi:10.5414/cpp46389","doi":"https://doi.org/10.5414/cpp46389","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp46389","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058830049","display_name":"Veli\u2010Pekka Harjola","orcid":"https://orcid.org/0000-0001-5351-0811","observed_orcids":["https://orcid.org/0000-0001-5351-0811"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"V.-P. Harjola","raw_affiliation_strings":["Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. veli-pekka.harjola@hus.fi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Emergency Care, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. veli-pekka.harjola@hus.fi","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044090184","display_name":"Lasse Oikarinen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Oikarinen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111850254","display_name":"L. Toivonen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Toivonen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048238366","display_name":"Raija Jurkko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Jurkko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048616120","display_name":"Jaakko Puttonen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Puttonen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002714845","display_name":"Toni Sarapohja","orcid":"https://orcid.org/0000-0002-1661-0853","observed_orcids":["https://orcid.org/0000-0002-1661-0853"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Sarapohja","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110178940","display_name":"S. Sundberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Sundberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5058664894","display_name":"Markku S. Nieminen","orcid":"https://orcid.org/0000-0002-3802-6738","observed_orcids":["https://orcid.org/0000-0002-3802-6738"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M.S. Nieminen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7063,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.74869765,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"46","issue":"08","first_page":"389","last_page":"399"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.9833999872207642,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/levosimendan","display_name":"levosimendan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/digoxin","display_name":"digoxin","score":1.0},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.9229999780654907},{"id":"https://openalex.org/keywords/chronic-heart-failure","display_name":"chronic heart failure","score":0.9110000133514404},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6830000281333923},{"id":"https://openalex.org/keywords/hemodynamics","display_name":"hemodynamics","score":0.8679999709129333},{"id":"https://openalex.org/keywords/systolic-time-intervals","display_name":"systolic time intervals","score":0.7269999980926514},{"id":"https://openalex.org/keywords/drug-induced-arrhythmia","display_name":"drug-induced arrhythmia","score":0.7300000190734863},{"id":"https://openalex.org/keywords/ventricular-repolarization","display_name":"ventricular repolarization","score":0.7379999756813049},{"id":"https://openalex.org/keywords/nonsustained-ventricular-tachycardia","display_name":"non-sustained ventricular tachycardia","score":0.8209999799728394}],"concepts":[{"id":"https://openalex.org/C2777707475","wikidata":"https://www.wikidata.org/wiki/Q422222","display_name":"Digoxin","level":3,"score":0.9796569347381592},{"id":"https://openalex.org/C2777335384","wikidata":"https://www.wikidata.org/wiki/Q162541","display_name":"Levosimendan","level":3,"score":0.9591253995895386},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7847704291343689},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5737350583076477},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5464871525764465},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.5333920121192932},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.5127180814743042},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4397753179073334},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.38765501976013184},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077464","descriptor_name":"Simendan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081","descriptor_name":"Acetamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004077","descriptor_name":"Digoxin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004562","descriptor_name":"Electrocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006333","descriptor_name":"Heart Failure","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006439","descriptor_name":"Hemodynamics","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053798","descriptor_name":"Magnetocardiography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5414/cpp46389","doi":"https://doi.org/10.5414/cpp46389","is_oa":false,"landing_page_url":"https://doi.org/10.5414/cpp46389","pdf_url":null,"source":{"id":"https://openalex.org/S166536441","display_name":"International Journal of Clinical Pharmacology and Therapeutics","issn_l":"0946-1965","issn":["0946-1965"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","medline","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310313675","host_organization_name":"Dustri-Verlag","host_organization_lineage":["https://openalex.org/P4310313675"],"host_organization_lineage_names":["Dustri-Verlag"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Int. Journal of Clinical Pharmacology and Therapeutics","raw_type":"journal-article"},{"id":"pmid:18793580","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18793580","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology and therapeutics","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2019057689","https://openalex.org/W2161035745","https://openalex.org/W2077338919","https://openalex.org/W1966138111","https://openalex.org/W1999065909","https://openalex.org/W1986034615","https://openalex.org/W2117229660","https://openalex.org/W1983463394","https://openalex.org/W2417968713","https://openalex.org/W2426925096"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Levosimendan":[1],"is":[2],"a":[3,70,173,310,329],"calcium-sensitizing":[4],"drug":[5],"for":[6,94],"the":[7,21,34,75,109,134,155,184,192,197,205,226,259,286,320,326,352],"treatment":[8,138,150],"of":[9,14,37,58,136,142,154,176,216,240,251,262,274,285,302,351],"heart":[10,44,56],"failure.":[11,45],"The":[12,99,221,269,282,300],"aim":[13],"this":[15,38],"exploratory":[16],"study":[17],"was":[18,102,112,199,215,229],"to":[19,79,171,180,279,305,319],"assess":[20],"hemodynamic":[22],"and":[23,28,83,90,108,124,132,144,159,234,238,289,295,334,341],"pharmacokinetic":[24,330],"interactions":[25],"between":[26,332],"digoxin":[27,82,89,110,145,185,193,212,227,252,306],"oral":[29,303],"levosimendan":[30,84,100,143,187,214,254,263,275,304,333],"as":[31,33],"well":[32],"proarrhythmic":[35,349],"potential":[36],"combination":[39],"in":[40,148,183,209,225,291],"patients":[41,50,76],"with":[42,54,191,323],"chronic":[43,55],"MATERIALS:":[46],"Male":[47],"or":[48,88],"female":[49],"(n":[51],"=":[52],"24)":[53],"failure":[57],"NYHA":[59],"Classes":[60],"II-III.":[61],"METHODS:":[62],"A":[63],"randomized,":[64],"placebo-controlled,":[65],"double-blind,":[66],"parallel-group":[67],"trial.":[68],"After":[69,248],"1-week":[71],"digoxin-free":[72],"washout":[73],"period,":[74],"were":[77,128,146,161,293],"randomized":[78],"receive":[80],"either":[81],"(digoxin":[85],"+":[86,186,213,253],"levosimendan),":[87],"placebo":[91],"(digoxin)":[92],"orally":[93],"14":[95],"+/-":[96],"2":[97,249],"days.":[98],"dose":[101,111],"1":[103],"mg":[104,114],"3":[105],"times":[106],"daily,":[107],"0.125-0.25":[113],"once":[115],"daily.":[116],"Systolic":[117],"time":[118],"intervals,":[119],"electrocardiography":[120],"(ECG),":[121],"magneto-cardiography":[122],"(MCG)":[123],"24-h":[125],"ambulatory":[126,342],"ECG":[127,233,343],"performed":[129],"at":[130,133,163,165],"baseline":[131,164,208,224],"end":[135],"each":[137],"period.":[139],"Pharmacokinetic":[140],"variables":[141],"calculated":[147],"both":[149],"periods.":[151],"Steady-state":[152],"concentrations":[153,284],"active":[156],"metabolites":[157,287],"OR-1855":[158,288],"OR-1896":[160,290],"determined":[162],"Visit":[166],"2.":[167],"RESULTS:":[168],"There":[169],"tended":[170],"be":[172],"greater":[174],"shortening":[175],"QS2i":[177,210],"(suggesting":[178],"trend":[179],"positive":[181],"inotropy)":[182],"group":[188,194,228],"(-14ms)":[189],"compared":[190],"(-5ms),":[195],"although":[196],"difference":[198],"not":[200,230,345],"statistically":[201,217,231,312],"significant":[202],"(p=0.359).":[203],"However,":[204],"change":[206,222],"from":[207,223,277,338],"after":[211],"borderline":[218],"significance":[219],"(p=0.05).":[220],"significant.":[232],"MCG":[235],"repolarization":[236,339],"measures":[237],"occurrence":[239],"nonsustained":[241],"ventricular":[242],"tachycardia":[243],"showed":[244],"no":[245],"substantial":[246],"differences.":[247],"weeks":[250],"treatment,":[255],"mean":[256,283],"area":[257],"under":[258],"curve":[260],"(AUC)":[261],"increased":[264,276],"approximately":[265],"by":[266],"49%":[267],"(p<0.01).":[268],"maximum":[270],"plasma":[271,292],"concentration":[272],"(Cmax)":[273],"17":[278],"23":[280],"ng/ml.":[281],"4.3":[294],"8.3":[296],"ng/ml,":[297],"respectively.":[298],"CONCLUSIONS:":[299],"addition":[301],"therapy":[307],"produced":[308],"only":[309],"modest":[311],"nonsignificant":[313],"additive":[314],"inotropic":[315],"effect.":[316],"In":[317],"contrast":[318],"earlier":[321],"data":[322],"intravenous":[324],"levosimendan,":[325],"results":[327],"indicate":[328,346],"interaction":[331],"digoxin.":[335],"Data":[336],"obtained":[337],"analyses":[340],"did":[344],"any":[347],"possible":[348],"effects":[350],"combination.":[353]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}